Titles
- Compounding certain beta-lactam products in shortage under Section 503A of the Federal Food, Drug, and Cosmetic Act: immediately in effect guidance for industry1
- Computer-assisted detection devices applied to radiology images and radiology device data: premarket notification [510(k)] submissions : guidance for industry and Food and Drug Administration staff1
- Connecticut Medicaid Fraud Control Unit: 2021 inspection1
- Considerations for a local health insurance option in Medicaid non-expansion states1
- Contact tracing for air travel: CDC’s data system needs substantial improvement : report to congressional addressees1
- Coordinating housing, health and LTSS through home-based care management1
- Cost savings1
- County-level drivers of disability benefit claims in times of COVID-191
- Coverage and cost effects of senators Bennet and Kaine’s Medicare-X Choice Act of 20211
- Creating an age-friendly plan for the New York State master plan for aging: summit report1
- Cross labeling oncology drugs in combination regimens: guidance for industry1
- Current good manufacturing practice and preventive controls, foreign supplier verification programs, intentional adulteration, and produce safety regulations: enforcement policy regarding certain provisions1
- Data elements for research on the role of social determinants of health in Coronavirus disease 2019: infection and outcomes in the U.S1
- Defense health agency: oversight needed to better ensure that children are screened, tested, and treated for lead exposure : report to congressional committees1
- Defense health care: Actions needed to improve billing and collection of debt for civilian emergency care : report to congressional committees1
- Defense health care: DOD expects new IT system capabilities to improve other health insurance processing : report to congressional committees1
- Defense health care: Prevalence of and efforts to screen and treat mental health conditions in prenatal and postpartum TRICARE beneficiaries : report to congressional committees1
- Delays in confirmatory trials for drug applications granted FDA’s accelerated approval raise concerns1
- Delivery reform1
- Demographic characteristics of adults receiving COVID-19 booster vaccinations1